BioCorRx Inc.
BICX
$0.35
$0.025.30%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 635.20K | 178.20K | 134.90K | 0.00 | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 635.20K | 178.20K | 134.90K | 0.00 | -- |
| Cost of Revenue | 358.80K | -- | -- | 0.00 | -- |
| Gross Profit | 276.40K | 178.20K | 134.90K | 0.00 | -- |
| SG&A Expenses | 1.15M | 1.22M | 886.10K | 839.20K | 1.19M |
| Depreciation & Amortization | 72.00K | 72.00K | 24.80K | 13.00K | 6.70K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.58M | 1.59M | 1.07M | 1.12M | 1.66M |
| Operating Income | -1.95M | -1.41M | -937.90K | -1.12M | -1.66M |
| Income Before Tax | -808.50K | -1.38M | -851.80K | -1.23M | -1.51M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -808.50K | -1.38M | -851.80K | -1.23M | -1.51M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -1.11M | 143.90K | 10.40K | 63.00K | 25.60K |
| Net Income | -1.92M | -1.23M | -841.40K | -1.16M | -1.49M |
| EBIT | -1.95M | -1.41M | -937.90K | -1.12M | -1.66M |
| EBITDA | -1.87M | -1.34M | -913.10K | -1.11M | -1.65M |
| EPS Basic | -0.11 | -0.07 | -0.06 | -0.09 | -0.14 |
| Normalized Basic EPS | -0.09 | -0.04 | -0.03 | -0.05 | -0.08 |
| EPS Diluted | -0.11 | -0.07 | -0.06 | -0.09 | -0.14 |
| Normalized Diluted EPS | -0.09 | -0.04 | -0.03 | -0.05 | -0.08 |
| Average Basic Shares Outstanding | 18.16M | 17.01M | 15.09M | 12.72M | 10.91M |
| Average Diluted Shares Outstanding | 18.16M | 17.01M | 15.09M | 12.72M | 10.91M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |